Larimar Therapeutics chief development officer buys $13,549 in stock
IN
Investing.comBy Investing.com
EXECUTIVE SUMMARY
Larimar Therapeutics chief development officer buys $13,549 in stock....
Key Takeaways
- Larimar Therapeutics chief development officer buys $13,549 in stock.
Read Complete Original Article
Published originally on Investing.com




